Vivimed Labs Ltd Share Price NSE India S.E.
Equities
INE526G01013
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
|
04/05 | Vivimed Labs Limited Announces Change in Corporate Office Address | CI |
26/02 | Vivimed Labs CFO Resigns | MT |
Sales 2022 | 2.39B 28.56M | Sales 2023 | 1.88B 22.52M | Capitalization | 547M 6.55M |
---|---|---|---|---|---|
Net income 2022 | -677M -8.11M | Net income 2023 | -3.28B -39.33M | EV / Sales 2022 | 1.98 x |
Net Debt 2022 | 3.52B 42.11M | Net Debt 2023 | 3.77B 45.17M | EV / Sales 2023 | 2.3 x |
P/E ratio 2022 |
-1.78
x | P/E ratio 2023 |
-0.17
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.35% |
Managers | Title | Age | Since |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 09/89/09 |
Compliance Officer | - | - | |
S. G. Saurabh
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 09/89/09 |
Sandeep Varalwar
BRD | Director/Board Member | 55 | 23/08/23 |
Subhash Varalwar
BRD | Director/Board Member | 76 | 09/89/09 |
1st Jan change | Capi. | |
---|---|---|
+54.80% | 815B | |
+44.25% | 654B | |
-6.38% | 354B | |
+21.75% | 337B | |
+10.78% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.83% | 171B |